Panbela schedules conference call on may 12, 2022, to report 2022 first quarter financial results

Minneapolis, april 26, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it will host a conference call on may 12, 2022 at 4:30 pm eastern time to discuss results for its first quarter ended march 31, 2022.
PBLA Ratings Summary
PBLA Quant Ranking